Variant report

Variant	nsv827730
Chromosome Location	chr16:73066699-73115642
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2876)
CpG islands
(count:3239)
Chromatin interactive
region (count:96)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:2876 , 50 per page) page: 1 2 3 4 5 6 7 ... 58

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:73102958-73103218	HepG2	liver:	n/a	n/a
2	ARID3A	chr16:73102528-73102669	HepG2	liver:	n/a	n/a
3	ARID3A	chr16:73087215-73090250	HepG2	liver:	n/a	chr16:73088864-73088880
4	ARID3A	chr16:73084597-73085062	HepG2	liver:	n/a	n/a
5	ARID3A	chr16:73090636-73091153	HepG2	liver:	n/a	n/a
6	ARID3A	chr16:73071770-73072481	HepG2	liver:	n/a	n/a
7	ARID3A	chr16:73095154-73095273	HepG2	liver:	n/a	n/a
8	ARID3A	chr16:73091578-73091755	HepG2	liver:	n/a	n/a
9	ARID3A	chr16:73082188-73082734	HepG2	liver:	n/a	n/a
10	ARID3A	chr16:73104388-73104786	HepG2	liver:	n/a	n/a
11	ATF1	chr16:73104432-73104715	K562	blood:	n/a	n/a
12	ATF1	chr16:73071357-73072529	K562	blood:	n/a	n/a
13	ATF1	chr16:73108297-73108646	K562	blood:	n/a	n/a
14	ATF2	chr16:73068149-73068598	GM12878	blood:	n/a	n/a
15	ATF2	chr16:73066451-73066916	H1-hESC	embryonic stem cell:	n/a	n/a
16	ATF2	chr16:73066443-73066902	H1-hESC	embryonic stem cell:	n/a	n/a
17	ATF2	chr16:73104275-73104898	H1-hESC	embryonic stem cell:	n/a	n/a
18	ATF2	chr16:73104316-73104885	H1-hESC	embryonic stem cell:	n/a	n/a
19	ATF2	chr16:73070195-73070493	H1-hESC	embryonic stem cell:	n/a	n/a
20	ATF2	chr16:73069813-73070389	GM12878	blood:	n/a	n/a
21	ATF2	chr16:73066242-73066828	GM12878	blood:	n/a	n/a
22	ATF2	chr16:73087249-73087798	H1-hESC	embryonic stem cell:	n/a	n/a
23	ATF3	chr16:73087187-73088225	A549	lung:	n/a	chr16:73087751-73087759 chr16:73087752-73087759 chr16:73087752-73087762 chr16:73087748-73087761 chr16:73087748-73087763
24	ATF3	chr16:73104341-73104821	A549	lung:	n/a	chr16:73104596-73104609
25	ATF3	chr16:73104313-73104866	A549	lung:	n/a	chr16:73104596-73104609
26	ATF3	chr16:73087152-73087977	A549	lung:	n/a	chr16:73087751-73087759 chr16:73087752-73087759 chr16:73087752-73087762 chr16:73087748-73087761 chr16:73087748-73087763
27	BACH1	chr16:73086789-73086897	H1-hESC	embryonic stem cell:	n/a	n/a
28	BACH1	chr16:73066543-73067273	H1-hESC	embryonic stem cell:	n/a	n/a
29	BACH1	chr16:73104338-73104852	H1-hESC	embryonic stem cell:	n/a	n/a
30	BACH1	chr16:73081480-73081892	H1-hESC	embryonic stem cell:	n/a	n/a
31	BACH1	chr16:73069271-73069284	H1-hESC	embryonic stem cell:	n/a	n/a
32	BACH1	chr16:73099903-73100238	H1-hESC	embryonic stem cell:	n/a	n/a
33	BACH1	chr16:73087258-73087631	H1-hESC	embryonic stem cell:	n/a	n/a
34	BACH1	chr16:73091594-73091724	H1-hESC	embryonic stem cell:	n/a	n/a
35	BACH1	chr16:73069867-73070575	H1-hESC	embryonic stem cell:	n/a	n/a
36	BACH1	chr16:73097037-73097082	H1-hESC	embryonic stem cell:	n/a	n/a
37	BACH1	chr16:73082469-73082587	H1-hESC	embryonic stem cell:	n/a	n/a
38	BATF	chr16:73068190-73068617	GM12878	blood:	n/a	chr16:73068385-73068394
39	BATF	chr16:73068154-73068531	GM12878	blood:	n/a	chr16:73068385-73068394
40	BCL11A	chr16:73068214-73068555	GM12878	blood:	n/a	chr16:73068476-73068485
41	BCL11A	chr16:73068223-73068561	GM12878	blood:	n/a	chr16:73068476-73068485
42	BCL11A	chr16:73066584-73066786	H1-hESC	embryonic stem cell:	n/a	n/a
43	BCL3	chr16:73104007-73104914	A549	lung:	n/a	n/a
44	BCL3	chr16:73087021-73088046	A549	lung:	n/a	chr16:73087952-73087965 chr16:73087255-73087268
45	BCL3	chr16:73081156-73081934	A549	lung:	n/a	chr16:73081601-73081614 chr16:73081788-73081801 chr16:73081614-73081627 chr16:73081913-73081926 chr16:73081731-73081740 chr16:73081709-73081722
46	BCL3	chr16:73081598-73082041	GM12878	blood:	n/a	chr16:73081601-73081614 chr16:73081788-73081801 chr16:73081614-73081627 chr16:73081913-73081926 chr16:73081731-73081740 chr16:73081709-73081722
47	BCL3	chr16:73086982-73087936	A549	lung:	n/a	chr16:73087255-73087268
48	BCL3	chr16:73089380-73090159	A549	lung:	n/a	n/a
49	BCL3	chr16:73104290-73104883	A549	lung:	n/a	n/a
50	BCLAF1	chr16:73071201-73071636	GM12878	blood:	n/a	chr16:73071238-73071247

(count:3239 , 50 per page) page: 1 2 3 4 5 6 7 ... 65

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:73085092-73085142	ProgFib	skin:	n/a
2	chr16:73093309-73093359	ProgFib	skin:	n/a
3	chr16:73092394-73092444	NHBE	bronchial:	n/a
4	chr16:73097142-73097192	HEK293	kidney:	embryo
5	chr16:73081124-73081174	HUVEC	blood vessel:	n/a
6	chr16:73100510-73100560	GM12891	blood:	n/a
7	chr16:73085092-73085142	ProgFib	skin:	n/a
8	chr16:73093309-73093359	ProgFib	skin:	n/a
9	chr16:73092394-73092444	NHBE	bronchial:	n/a
10	chr16:73097142-73097192	HEK293	kidney:	embryo
11	chr16:73081124-73081174	HUVEC	blood vessel:	n/a
12	chr16:73100510-73100560	GM12891	blood:	n/a
13	chr16:73100510-73100560	BJ	skin:	n/a
14	chr16:73100426-73100476	K562	blood:	n/a
15	chr16:73091565-73091615	MCF-7	breast:	n/a
16	chr16:73096966-73097016	Caco-2	colon:	n/a
17	chr16:73085092-73085142	HCM	heart:	n/a
18	chr16:73090723-73090773	SAEC	small airway:	n/a
19	chr16:73100790-73100840	ovcar-3	ovarian:	n/a
20	chr16:73092391-73092441	PrEC	prostate:	n/a
21	chr16:73096894-73096944	BJ	skin:	n/a
22	chr16:73096894-73096944	ECC-1	luminal epithelium:	n/a
23	chr16:73100510-73100560	HRE	kidney:	n/a
24	chr16:73083327-73083377	NB4	blood:	n/a
25	chr16:73067525-73067575	SKMC	muscle:	n/a
26	chr16:73104388-73104438	HAEpiC	amniotic membrane:	n/a
27	chr16:73082051-73082101	ProgFib	skin:	n/a
28	chr16:73104388-73104438	BJ	skin:	n/a
29	chr16:73099184-73099234	PFSK-1	brain:	n/a
30	chr16:73067525-73067575	GM06990	blood:	n/a
31	chr16:73090838-73090888	GM12878	blood:	n/a
32	chr16:73104816-73104866	Hepatocyte	liver:	n/a
33	chr16:73097142-73097192	NB4	blood:	n/a
34	chr16:73078071-73078121	AG04450	lung:	fetal
35	chr16:73100510-73100560	HNPCEpiC	eye:	n/a
36	chr16:73099184-73099234	HIPEpiC	eye:	n/a
37	chr16:73099892-73099942	A549	lung:	n/a
38	chr16:73092391-73092441	AG10803	skin:	n/a
39	chr16:73104816-73104866	NHDF-neo	bronchial:	n/a
40	chr16:73104388-73104438	HepG2	liver:	n/a
41	chr16:73099565-73099615	HepG2	liver:	n/a
42	chr16:73068480-73068530	HEK293	kidney:	embryo
43	chr16:73097903-73097953	PrEC	prostate:	n/a
44	chr16:73080909-73080959	PANC-1	pancreas:	n/a
45	chr16:73099184-73099234	HRCEpiC	kidney:	n/a
46	chr16:73099892-73099942	GM19239	blood:	n/a
47	chr16:73092391-73092441	GM12892	blood:	n/a
48	chr16:73096966-73097016	AG09319	gingival:	n/a
49	chr16:73068480-73068530	ProgFib	skin:	n/a
50	chr16:73102243-73102293	SK-N-MC	brain:	n/a

(count:96 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr16:73082425..73084366-chr16:73087319..73089804,2	K562	blood:
2	chr16:73079572..73082318-chr20:47893327..47894855,2	MCF-7	breast:
3	chr16:73081344..73082144-chr16:73090114..73090753,2	MCF-7	breast:
4	chr16:73091557..73092421-chr16:73102683..73103243,2	Hela-S3	cervix:
5	chr16:73103273..73105609-chr6:110532483..110534690,2	MCF-7	breast:
6	chr10:126604774..126605466-chr16:73081008..73081765,2	HCT-116	colon:
7	chr16:73011522..73014145-chr16:73090435..73093008,2	MCF-7	breast:
8	chr16:72535525..72537335-chr16:73089381..73091034,2	MCF-7	breast:
9	chr16:72960498..72962274-chr16:73101154..73102680,2	MCF-7	breast:
10	chr16:73088044..73089636-chr2:188441847..188444162,2	MCF-7	breast:
11	chr16:73085960..73092476-chr16:73227779..73233499,9	MCF-7	breast:
12	chr16:72833626..72835422-chr16:73088428..73090096,2	MCF-7	breast:
13	chr16:73061047..73064506-chr16:73066434..73068183,3	MCF-7	breast:
14	chr16:73061921..73064545-chr16:73083761..73085497,2	K562	blood:
15	chr16:72820675..72822937-chr16:73088411..73090468,2	MCF-7	breast:
16	chr16:72947016..72947886-chr16:73089092..73089868,3	MCF-7	breast:
17	chr16:72695949..72698024-chr16:73089011..73091874,2	MCF-7	breast:
18	chr16:72878570..72880938-chr16:73094933..73097735,2	MCF-7	breast:
19	chr16:73089985..73092760-chr17:56736244..56737913,2	MCF-7	breast:
20	chr16:73102510..73107016-chr16:73224696..73227823,4	MCF-7	breast:
21	chr16:72899692..72902233-chr16:73090412..73092893,2	MCF-7	breast:
22	chr16:73013583..73015473-chr16:73077986..73080970,2	MCF-7	breast:
23	chr16:73105729..73106412-chr16:73209983..73210731,2	MCF-7	breast:
24	chr16:73089824..73092143-chr18:3251149..3252786,2	MCF-7	breast:
25	chr16:73082165..73082838-chr3:119182253..119183080,2	Hela-S3	cervix:
26	chr12:48212786..48214418-chr16:73090637..73093148,2	MCF-7	breast:
27	chr16:72942949..72944486-chr16:73103270..73105175,2	MCF-7	breast:
28	chr16:73103583..73105787-chr16:73124899..73127498,2	MCF-7	breast:
29	chr16:72954117..72957535-chr16:73090065..73093050,3	MCF-7	breast:
30	chr16:73067802..73070400-chr16:73071930..73073928,2	K562	blood:
31	chr16:72849283..72851789-chr16:73089410..73091009,2	MCF-7	breast:
32	chr16:72975304..72978411-chr16:73089812..73092713,3	MCF-7	breast:
33	chr16:73088393..73091029-chr16:73316559..73318962,2	MCF-7	breast:
34	chr16:73103881..73106291-chr16:73193868..73198572,4	MCF-7	breast:
35	chr16:72889542..72892358-chr16:73091251..73093063,3	MCF-7	breast:
36	chr16:72999501..73001518-chr16:73089190..73091983,2	MCF-7	breast:
37	chr16:73046781..73051112-chr16:73086849..73089877,3	MCF-7	breast:
38	chr16:72865444..72867125-chr16:73097425..73099018,2	MCF-7	breast:
39	chr16:72876716..72878978-chr16:73099267..73102031,2	MCF-7	breast:
40	chr16:73102544..73103164-chr17:33307645..33308503,2	Hela-S3	cervix:
41	chr16:72994804..72996648-chr16:73085703..73088128,2	MCF-7	breast:
42	chr16:72943044..72944852-chr16:73087640..73090258,2	MCF-7	breast:
43	chr16:73082425..73084366-chr16:73087319..73089804,2	K562	blood:
44	chr16:73067802..73070400-chr16:73071930..73073928,2	K562	blood:
45	chr16:72865125..72866721-chr16:73087210..73088768,2	MCF-7	breast:
46	chr16:73052788..73055370-chr16:73088414..73091315,3	MCF-7	breast:
47	chr16:73089699..73092181-chr9:100817965..100820433,2	MCF-7	breast:
48	chr16:73080238..73082022-chr16:73230296..73232241,3	MCF-7	breast:
49	chr16:72808782..72811039-chr16:73094813..73097689,2	MCF-7	breast:
50	chr16:72961643..72964004-chr16:73079315..73080843,2	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RP11-44L9.1.1-12	chr16:73094279-73096215	NONHSAT143628
2	lnc-RP11-44L9.1.1-12	chr16:73094369-73096215	ENSG00000271009.2
3	lnc-RP11-44L9.1.1-12	chr16:73094144-73094658	ENSG00000272250.1
4	lnc-RP11-44L9.1.1-12	chr16:73093800-73095621	NONHSAT143627

No data

Variant related genes	Relation type
ZFHX3	TF binding region
ENSG00000272250	TF binding region
ENSG00000271009	TF binding region
ZFHX3	CpG island
ENSG00000272250	CpG island
ENSG00000271009	CpG island
ENSG00000061273	chromatin interactions
ENSG00000124201	chromatin interactions
ENSG00000077147	chromatin interactions
ENSG00000273015	chromatin interactions
ENSG00000103035	chromatin interactions
ENSG00000005156	chromatin interactions
ENSG00000221799	chromatin interactions
ENSG00000266402	chromatin interactions
ENSG00000132141	chromatin interactions
ENSG00000199004	chromatin interactions
ENSG00000260880	chromatin interactions
ENSG00000095380	chromatin interactions
ENSG00000199753	chromatin interactions
ENSG00000176142	chromatin interactions
ENSG00000148057	chromatin interactions
ENSG00000265573	chromatin interactions
ENSG00000272330	chromatin interactions
ENSG00000261008	chromatin interactions
ENSG00000177410	chromatin interactions
ENSG00000259768	chromatin interactions
ENSG00000261404	chromatin interactions
ENSG00000202077	chromatin interactions
ENSG00000101608	chromatin interactions

Extended variants
information (count: 1867 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:1867 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs188548220	chr16:73066731-73066732	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
2	rs145252218	chr16:73066772-73066773	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
3	rs376632565	chr16:73066785-73066786	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
4	rs193154421	chr16:73066853-73066854	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs577801758	chr16:73066854-73066855	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs369871834	chr16:73066855-73066856	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs184770537	chr16:73066900-73066901	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs555347215	chr16:73066909-73066910	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs560212337	chr16:73066910-73066911	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs573568720	chr16:73066935-73066936	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs11646668	chr16:73066954-73066955	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs558943828	chr16:73067052-73067053	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs577286883	chr16:73067092-73067093	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs544343370	chr16:73067135-73067136	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs531861506	chr16:73067143-73067144	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs188090736	chr16:73067154-73067155	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs28688024	chr16:73067155-73067156	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs541617058	chr16:73067235-73067236	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs574168021	chr16:73067236-73067237	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs369276839	chr16:73067261-73067262	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs147624016	chr16:73067373-73067374	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs368592969	chr16:73067374-73067375	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs117107922	chr16:73067378-73067379	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs12925866	chr16:73067381-73067382	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs115327197	chr16:73067388-73067389	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs531275195	chr16:73067393-73067394	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs12929448	chr16:73067416-73067417	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs12929811	chr16:73067418-73067419	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs374824833	chr16:73067423-73067424	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs117458916	chr16:73067430-73067431	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs568143160	chr16:73067433-73067434	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs59741667	chr16:73067435-73067436	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs536888023	chr16:73067532-73067533	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs80276927	chr16:73067562-73067563	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs142145755	chr16:73067581-73067582	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs376748530	chr16:73067592-73067593	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs142244201	chr16:73067600-73067601	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs577200540	chr16:73067601-73067602	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs370966346	chr16:73067613-73067614	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs876726	chr16:73067636-73067637	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs191481400	chr16:73067651-73067652	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs541630126	chr16:73067656-73067657	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs559888214	chr16:73067695-73067696	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs567769645	chr16:73067742-73067743	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs183680489	chr16:73067755-73067756	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs374972783	chr16:73067756-73067757	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs545727527	chr16:73067760-73067761	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs876727	chr16:73067761-73067762	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs377572152	chr16:73067773-73067774	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs531254720	chr16:73067796-73067797	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute myeloid leukemia	16864856	CNVD
Infiltrating lobular breast cancer	19191266	CNVD
T-cell lymphomas	19863542	CNVD
Hepatocellular carcinoma	16750200	CNVD
Medulloblastoma	16783165	CNVD
Neuroblastoma	21899760	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	18628472	CNVD
Breast cancer	21806811	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	21509527	CNVD
Melanoma	22183965	CNVD
small cell lung cancer	20016488	CNVD
Ependymoma	18628472	CNVD
Ewing''s sarcoma	18628472	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	17160897	CNVD
Breast cancer	20409316	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:3549 , 50 per page) page: 1 2 3 4 5 6 7 ... 71

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:73049400-73069200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
2	chr16:73055200-73076400	Weak transcription	Brain Angular Gyrus	brain
3	chr16:73059000-73072000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
4	chr16:73059400-73076400	Weak transcription	Sigmoid Colon	Sigmoid Colon
5	chr16:73059600-73067000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr16:73059600-73069800	Weak transcription	Rectal Mucosa Donor 29	rectum
7	chr16:73059800-73069600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
8	chr16:73059800-73070000	Weak transcription	Colonic Mucosa	Colon
9	chr16:73060000-73066800	Weak transcription	Aorta	Aorta
10	chr16:73060000-73067200	Weak transcription	Duodenum Smooth Muscle	Duodenum
11	chr16:73060000-73067800	Weak transcription	Brain Substantia Nigra	brain
12	chr16:73060600-73072600	Enhancers	Fetal Lung	lung
13	chr16:73061200-73070000	Enhancers	Placenta	Placenta
14	chr16:73062400-73071800	Weak transcription	Spleen	Spleen
15	chr16:73062600-73068200	Weak transcription	Right Ventricle	heart
16	chr16:73062800-73069800	Weak transcription	Stomach Mucosa	stomach
17	chr16:73063200-73066800	Weak transcription	Right Atrium	heart
18	chr16:73063200-73070200	Weak transcription	Esophagus	oesophagus
19	chr16:73063200-73073800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
20	chr16:73063800-73067000	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
21	chr16:73063800-73068400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
22	chr16:73064000-73066800	Enhancers	Fetal Intestine Small	intestine
23	chr16:73064400-73067000	Weak transcription	Gastric	stomach
24	chr16:73064600-73068200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr16:73064600-73070000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr16:73064600-73074400	Enhancers	Skeletal Muscle Male	skeletal muscle
27	chr16:73064800-73066800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
28	chr16:73064800-73067000	Enhancers	HepG2	liver
29	chr16:73064800-73067200	Enhancers	Brain Cingulate Gyrus	brain
30	chr16:73064800-73067400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr16:73064800-73067600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
32	chr16:73064800-73069200	Enhancers	Brain Anterior Caudate	brain
33	chr16:73064800-73069800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr16:73065000-73067600	Enhancers	Skeletal Muscle Female	skeletal muscle
35	chr16:73065200-73067000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
36	chr16:73065200-73067200	Enhancers	Rectal Mucosa Donor 31	rectum
37	chr16:73065200-73067600	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
38	chr16:73065200-73068000	Enhancers	Colon Smooth Muscle	Colon
39	chr16:73065200-73068600	Enhancers	Fetal Kidney	kidney
40	chr16:73065200-73069800	Enhancers	Primary hematopoietic stem cells short term culture	blood
41	chr16:73065200-73070200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr16:73065200-73072400	Enhancers	Fetal Muscle Leg	muscle
43	chr16:73065200-73072600	Enhancers	Placenta Amnion	Placenta Amnion
44	chr16:73065200-73074000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
45	chr16:73065400-73067600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
46	chr16:73065400-73068800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr16:73065400-73069200	Enhancers	Fetal Stomach	stomach
48	chr16:73065600-73066800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
49	chr16:73065600-73067000	Enhancers	Fetal Muscle Trunk	muscle
50	chr16:73065600-73067600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links